02.08.18
Amyris, Inc.’s joint venture with the Nikkol Group, Aprinnova, has launched pharmaceutical grade Neossance Squalane USP. This new material meets the industry standards required by the United States Pharmacopeia (USP) and the National Formulary (NF) for drug actives and pharmaceutical excipients, which are used by regulatory agencies and manufacturers. As a result, Aprinnova is now able to supply these industries with FDA-regulated sugarcane-derived squalane, which was previously unavailable to these markets since shark-derived squalane was the only source reference in the regulatory monograph for squalane.
Amyris's Aprinnova cosmetic ingredients joint venture has now delivered over 50% annual revenue growth since the joint venture was announced and is the leading source of one of the world's leading natural skin nourishment ingredients. This approval enables significant expansion of this business across numerous product applications. These include topical and dermal cosmetic applications such as therapeutic skin creams and ointments.
"We are very pleased to have met the USP and NF requirements, which showcases our adherence to a philosophy of manufacturing and distributing the highest performance, sustainable products through a best-in-class production process," said Caroline Hadfield, Senior Vice President of Personal Care at Amyris. "We are delighted to provide a sustainable and naturally-sourced squalane to this important new market for Aprinnova while providing our customers and their end market customers with non-animal, cruelty-free high-performance ingredients for a growing variety of products."
More info: www.amyris.com
Amyris's Aprinnova cosmetic ingredients joint venture has now delivered over 50% annual revenue growth since the joint venture was announced and is the leading source of one of the world's leading natural skin nourishment ingredients. This approval enables significant expansion of this business across numerous product applications. These include topical and dermal cosmetic applications such as therapeutic skin creams and ointments.
"We are very pleased to have met the USP and NF requirements, which showcases our adherence to a philosophy of manufacturing and distributing the highest performance, sustainable products through a best-in-class production process," said Caroline Hadfield, Senior Vice President of Personal Care at Amyris. "We are delighted to provide a sustainable and naturally-sourced squalane to this important new market for Aprinnova while providing our customers and their end market customers with non-animal, cruelty-free high-performance ingredients for a growing variety of products."
More info: www.amyris.com